Delivery Order SPE2DX15D6028-B544
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,328.58 firm fixed-price delivery order is for the supply of Cephalexin 250 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 with the DLA Troop Support Medical. The IDC serves as the primary vehicle for...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $13,309.59 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract provides for the supply of 4566614119 - Cephalexin 250 mg/5 ml suspension, 200 ml, a generic antibiotic medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,417.39 firm fixed-price delivery order contract is for the supply of 4565924257 Cephalexin 500 mg tablets, with a completion date of September 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,725.49 firm fixed-price delivery order is for the supply of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication. The contract has an ultimate completion date of September 27, 2023 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,107.45, is for the supply of Cephalexin 500 mg capsules. This is a delivery order under an Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,543.56 contract is for the delivery of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication, to support military treatment facilities and other federal medical institutions. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This federal contract award, with the ID SPE2DB22D3016|SPE2DB24FBCP0, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,103.25 firm fixed price delivery order is for the supply of 4,565,297,714 units of the pharmaceutical product Cephalexin 500 mg capsules. The contract has an ultimate completion date of July 31, 2024 and does not have a set-aside designation. Amerisourcebergen is a major supplier of...
- This contract award, valued at $38,784.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of cephalexin 250 mg/5 ml suspension, a generic antibiotic medication, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- This federal contract award, with ID SPE2DB20D1109|SPE2DB25FN53C, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,222,503 units of Cephalexin 500 mg capsules, a generic antibiotic medication. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,318.96 and a completion date of February 11, 2025. The contract is not designated as a...
- This federal contract award, with ID SPE2DX16D1914|SPE2DX24FNSN1, is for the delivery of 4,565,798 units of Cephalexin 500mg 500S, a pharmaceutical product. The contract, valued at $4,183.00, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has a firm fixed price and an ultimate completion date of September 16, 2024. Amerisourcebergen holds several Indefinite Delivery...
- SPE2DX15D6028Indefinite Delivery Contract
- SPE2DX15D6028-B544Delivery Order
The federal contract award SPE2DX15D6028|B544 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $141,228.00 firm fixed-price delivery order is for Cephalexin 500mg tablets, a generic antibiotic medication. This award is associated with Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen is the prime contractor on this award, and its parent company is Cencora, Inc. This contract supports the DLA's mission to provide medical products and services to the U.S. Department of Defense and other federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $141.2k | 9/29/15 |